RIL
MDGL icon

Rothschild Investment LLC’s Madrigal Pharmaceuticals MDGL Stock Holding History

Rothschild Investment LLC’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$15.7K Buy
30
+6
+25% +$2.87K ﹤0.01% 1510
2025
Q4 		$14K Hold
24
– – ﹤0.01% 1456
2025
Q3 		$11K Sell
24
-3
-11% -$1.12K ﹤0.01% 1404
2025
Q2 		$8.17K Sell
27
-6
-18% -$1.79K ﹤0.01% 1299
2025
Q1 		$10.9K Buy
33
+13
+65% +$4.27K ﹤0.01% 1149
2024
Q4 		$6.17K Buy
20
+3
+18% +$844 ﹤0.01% 1280
2024
Q3 		$3.61K Buy
17
+11
+183% +$2.81K ﹤0.01% 1417
2024
Q2 		$1.68K Buy
6
+5
+500% +$1.19K ﹤0.01% 1451
2024
Q1 		$267 Buy
+1
New +$236 ﹤0.01% 1612

Other funds holding MDGL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return